Andrew Jackson, Chief Financial Officer
Mr. Jackson joins us with over 20 years of finance experience. Prior to joining AltheaDx, Mr. Jackson was Chief Financial Officer and Principal Accounting Officer of Celladon Corporation, a publicly traded, clinical stage biotechnology company. During his time at Celladon, Mr. Jackson scaled the company through its growth and led Celladon’s public company compliance following its Initial Public Offering and completed the company’s accretive merger with Eiger Biopharmceuticals. Prior to Celladon, Mr. Jackson held senior finance positions at various life science and technology companies where he had extensive experience with mergers & acquisitions, treasury management, capital & debt financing and financial planning. He holds a B.S.B in Accounting from the University of Minnesota, an M.B.A in Finance from San Diego State University and is a Certified Public Accountant.